As well as the established working parties on Safety of Residues (see 4.3), Pharmacovigilance, Immunological and Quality (joint CVMP/ CPMP), the Efficacy Working Party was reconvened in 1997 as a result of the Committee’ s decision to review existing guidelines where justified, and to consider new topics where further guidance is required.